Urokinase inhibitor activity was demonstrated only in G-II and G-IlI of infected mice representing 800 of recovery, but not in G-I or those of noninfected mice.
Plasmin inhibition was, however, found in all peaks. Column size, 15 x 780mm; buffer solution, 0.05 M Tris-HC1+0.1M NaCI buffer (pH 7.4); volume of a fraction, 2.5 ml. Table 1 Inhibition of urokinase and plasmin by hepatic extracts.
A) Each 1.0 ml of tissue extracts was mixed with 0.1 ml of UK solution and set in a water bath (37C) for 5 minutes. The mixture (0.1 ml) was then drawn and transfered in a cuvette containing 0.8 ml of 0.05M Tris-HC1 buffer (pH 8.8) and 0.1 ml of the substrate solution. Concentration of para-nitroaniline liberated by UK was continuously measured by A405 at 37C. Final concentrations of UK and the substrate were 13.0 CTA u/ml and 0.12 mM, respectively.
Concentration of the extract protein was ca. 1.45 mg/ml in the reaction mixture.
Degrees of inhibition were expressed by units of UK, since inhibition was found stoichiometrical (ref. 5). B) Each 0.5 ml of extracts was mixed with 0.5 ml of UK-activated plasmin and placed in an ice bath for 5 minutes. Then, 0.1 ml of the mixture was added to 0.8 ml of prewarmed 0.05 M Tris-HC1 buffer (pH 7. 4) and 0.1 ml of the substrate solution.
Final concentrations of plasmin and the substrate were 0.0142 CTA u/ml and 0.4 mM, respectively.
Concentration of the extract protein was finally ca. 1.9 mg/ml.
Measurements and expressions of inhibition were done in the same way as in A). 
